BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27434296)

  • 21. The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experience.
    Dogan M; Eren T; Ozdemir N; Cigirgan CL; Zengin N
    Saudi J Gastroenterol; 2015; 21(5):320-4. PubMed ID: 26458860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma.
    Huang J; Yuan Y; Wang Y; Zhang J; Kong W; Chen H; Chen Y; Huang Y
    Oncotarget; 2017 May; 8(22):36761-36771. PubMed ID: 27901490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes and prognostic markers in gallbladder cancer.
    Cui X; Zhu S; Tao Z; Deng X; Wang Y; Gao Y; Liao Y; Ma W; Zhang Y; Ma X
    Medicine (Baltimore); 2018 Jul; 97(28):e11396. PubMed ID: 29995783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
    Qi Q; Geng Y; Sun M; Wang P; Chen Z
    Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing prognostic value of preoperative platelet indexes in patients with resectable gastric cancer.
    Shi H; Wang H; Pan J; Liu Z; Li Z
    Sci Rep; 2022 Apr; 12(1):6480. PubMed ID: 35444195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of an inflammation-based prognostic system for gastric cancer patients with a preoperative normal serum level of carcinoembryonic antigen.
    Ishizuka M; Oyama Y; Abe A; Tago K; Tanaka G; Kubota K
    Anticancer Res; 2014 Dec; 34(12):7219-26. PubMed ID: 25503152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery.
    Mimatsu K; Fukino N; Ogasawara Y; Saino Y; Oida T
    Anticancer Res; 2017 Aug; 37(8):4215-4222. PubMed ID: 28739709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.
    Graziosi L; Marino E; De Angelis V; Rebonato A; Cavazzoni E; Donini A
    Am J Surg; 2015 Feb; 209(2):333-7. PubMed ID: 25190544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
    Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
    Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
    Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M
    J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.
    Fan W; Zhang Y; Wang Y; Yao X; Yang J; Li J
    PLoS One; 2015; 10(3):e0119312. PubMed ID: 25742141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment.
    Aliustaoglu M; Bilici A; Ustaalioglu BB; Konya V; Gucun M; Seker M; Gumus M
    Med Oncol; 2010 Dec; 27(4):1060-5. PubMed ID: 19847679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative lymphocyte-to-monocyte ratio (LMR) could independently predict overall survival of resectable gastric cancer patients.
    Pan YC; Jia ZF; Cao DH; Wu YH; Jiang J; Wen SM; Zhao D; Zhang SL; Cao XY
    Medicine (Baltimore); 2018 Dec; 97(52):e13896. PubMed ID: 30593200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer.
    Namikawa T; Munekage E; Munekage M; Maeda H; Yatabe T; Kitagawa H; Kobayashi M; Hanazaki K
    Oncology; 2016; 90(6):321-6. PubMed ID: 27225990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component.
    Zhu Z; Gao J; Liu Z; Li C; Xue Y
    Biomed Res Int; 2021; 2021():9678363. PubMed ID: 33997045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
    Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.